title: Cochrane systematic reviews of treatments for lung cancer.
abstract: Morbidity and mortality from lung cancer is a major burden to global health. The integration of expert clinical experience, patient preference and high-quality evidence, including Cochrane systematic reviews, can only help improve outcomes from this highly lethal condition.
authors.affiliation: Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Australia. Kwun_fong@health.qld.gov.au
authors.forename: K M
authors.initials: KM
authors.lastname: Fong
authors.forename: I A
authors.initials: IA
authors.lastname: Yang
authors.forename: P V
authors.initials: PV
authors.lastname: Zimmerman
authors.forename: R V
authors.initials: RV
authors.lastname: Bowman
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy; D018288:Carcinoma, Small Cell / Q000628:therapy; D019317:Evidence-Based Medicine; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D008403:Mass Screening / Q000379:methods; D012196:Review Literature as Topic; D016540:Smoking Cessation